Drug Integrated Polymer Fibers Market - Global Industry Analysis

Drug Integrated Polymer Fibers Market: by Type (Polylactic Acid, Polydioxanone, Polycaprolactone, and Others), by Application (Drug Delivery, Orthopedic Sutures, Vascular Stents, Vascular Grafts, Dermal Wound Healing, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2019 - 2025

Published Date: 13-Nov-2019 Category: Medical Device Report Format : PDF Pages: 130 Report Code: ZMR-5044 Status : Published

Description

According to the report, global demand for global drug integrated polymer fibers market was valued at USD 57.0 million in 2018, and is expected to generate revenue of USD 90.3 million by end of 2025, growing at a CAGR of 6.8% between 2019 and 2025

The report covers forecast and analysis for the global drug integrated polymer fibers market. The study provides historic data from 2016 to 2018 along with forecast from 2019 to 2025 based on revenue (USD Million). In-depth secondary research is used to ascertain overall market size, top industry players, top product, industry associations, etc. Macro-economic indicators such as healthcare industry outlook, healthcare spending, research funding, GDP along with company websites, company annual reports, white papers, financial reports and other sources have also been considered to arrive at the indicated market numbers.

Global Drug Integrated Polymer Fibers Market

The drug integrated polymers fibers are usually made of biocompatible and biodegradable materials. These fibers are also known as pharmaceutical fibers as these can be loaded with a variety of drugs. These polymers fibers are usually available in knitted/ braided or woven form used in medical textile devices. These fibers have wide range of applications in vascular grafts, orthopedics, drug delivery, and vascular stents along with dermal healing.

The study provides a decisive view on the drug integrated polymer fibers market by segmenting the market based on type, application, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2027.The drug integrated polymer fibers market is segmented on the basis of type into polydioxanone, polycaprolactone, polylactic acid, and others. Polylactic acid segment and its derivatives are anticipated to lead the market in drug integrated polymer fibers market. The growth of this segment is owing to the properties of polylactic acid (PLA) such as stable biocompatibility, and biodegradability of the material. The segment accounted for more approximately 45% share of the market growing at a high CAGR during the forecast period.

Drug delivery, dermal wound healing, vascular stents, orthopedic sutures, vascular grafts, and others are the key application segments of the drug integrated polymer fibers market. The orthopedic sutures segment dominated the market in terms of revenue in 2018. Whereas the drug delivery segment is anticipated to grow at significant growth rate over the forecast period, owing to increasing adoption of polymer fibers in drug delivery systems. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and Middle East & Africa with its further bifurcation into major countries.

The study also includes drivers and restraints for the drug integrated polymer fibers along with the impact they have on the demand over the forecast period. Besides, the report includes the study of opportunities and trends available in the drug integrated polymer fibers market on global level. Rapid development in the field of biotechnology and medicines has headed the drug discovery market towards growth of countless new, exceedingly potent and target-specific drug candidates. Inspite of firm pace of research and early-stage discovery, several drug candidates fail through preclinical assessment due to limited bioavailability, poor efficacy, and many other limitations related to effective drug delivery. Small molecule drugs undergo from poor stability, low solubility, non-specific toxicity, and short circulation time thus restraining their therapeutic efficiency. Biopharmaceuticals like proteins, nucleic acids, and peptides are usually restricted by low stability and hasty clearance from the body. These limitations, along with the diversity and complexity of new pharmaceuticals, are powering the evolution of novel and innovative drug delivery systems which will overcome the delivery obstacles and bioavailability. Though, in spite of the rising significance of polymer drug delivery practices, the methods and materials of drug delivery systems do not broadly exist to those in the external polymer synthesis field.

The report also provides company market share analysis in order to give a broader view of the key players in the market. Industry insights and information is delivered in the required format. ZMR develops a list of industry players (manufacturers), distributors, retailers and industry experts. Some of the players within global drug integrated polymer fibers market include TissueGen, Inc., Integrated Polymer Solutions, and Micro Engineering Solutions.

This report segments the global drug integrated polymer fibers market as follows:

Global Drug Integrated Polymer Fibers Market: Type Segment Analysis

  • Polylactic Acid (PLA)
  • Polydioxanone (PDO)
  • Polycaprolactone (PCL)
  • Others (PGA, PLGA, PDLL)

Global Drug Integrated Polymer Fibers Market: Application Segment Analysis

  • Drug Delivery
  • Orthopedic Sutures
  • Vascular Stents
  • Vascular Grafts
  • Dermal Wound Healing
  • Others

Global Drug Integrated Polymer Fibers Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Drug Integrated Polymer Fibers Market, 2016-2025 (USD Million)
    • 2.2. Drug Integrated Polymer Fibers Market: Snapshot
  • Chapter 3. Drug Integrated Polymer Fibers Market - Industry Analysis
    • 3.1. Drug Integrated Polymer Fibers Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Driver 1
      • 3.2.2. Driver 2
    • 3.3. Restraints
      • 3.3.1. Restraint 1
      • 3.3.2. Restraint 2
    • 3.4. Opportunity
      • 3.4.1. Government funding and support
    • 3.5. Porter's Five Forces Analysis
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis By Type
      • 3.6.2. Market attractiveness analysis By Application
      • 3.6.3. Market attractiveness analysis by Region
  • Chapter 4. Drug Integrated Polymer Fibers Market- Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Drug Integrated Polymer Fibers Market: company market share, 2018
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Type launches
      • 4.2.3. Agreements, partnerships, collaborations and joint ventures
      • 4.2.4. Research and development and Regional expansion
    • 4.3. Price trend analysis
  • Chapter 5. Global Drug Integrated Polymer Fibers Market - By Type Analysis
    • 5.1. Global Drug Integrated Polymer Fibers Market overview: By Type
      • 5.1.1. Global Drug Integrated Polymer Fibers Marketshare, By Type,2018 and 2025
    • 5.2. Polylactic Acid (PLA)
      • 5.2.1. Global Drug Integrated Polymer Fibers Market by Polylactic Acid (PLA), 2016-2025 (USD Million)
    • 5.3. Polydioxanone (PDO)
      • 5.3.1. Global Drug Integrated Polymer Fibers Market by Polydioxanone (PDO), 2016-2025 (USD Million)
    • 5.4. Polycaprolactone (PCL)
      • 5.4.1. Global Drug Integrated Polymer Fibers Market by Polycaprolactone (PCL), 2016-2025 (USD Million)
    • 5.5. Others (PGA, PLGA, PDLL)
      • 5.5.1. Global Drug Integrated Polymer Fibers Market by others (PGA, PLGA, PDLL), 2016-2025 (USD Million)
  • Chapter 6. Global Drug Integrated Polymer Fibers Market -Application Analysis
    • 6.1. Global Drug Integrated Polymer Fibers Market overview: By Application
      • 6.1.1. Global Drug Integrated Polymer Fibers Market share, By Application, 2018 and 2025
    • 6.2. Drug Delivery
      • 6.2.1. Global Drug Integrated Polymer Fibers Market By Drug Delivery, 2016-2025 (USD Million)
    • 6.3. Orthopedic Sutures
      • 6.3.1. Global Drug Integrated Polymer Fibers MarketBy Orthopedic Sutures, 2016-2025 (USD Million)
    • 6.4. Vascular Stents
      • 6.4.1. Global Drug Integrated Polymer Fibers Market By Vascular Stents, 2016-2025 (USD Million)
    • 6.5. Vascular Grafts
      • 6.5.1. Global Drug Integrated Polymer Fibers Market By Vascular Grafts, 2016-2025 (USD Million)
    • 6.6. Dermal Wound Healing
      • 6.6.1. Global Drug Integrated Polymer Fibers Market by Dermal Wound Healing, 2016-2025 (USD Million)
    • 6.7. Others
      • 6.7.1. Global Drug Integrated Polymer Fibers Market by Other Applications, 2016-2025 (USD Million)
  • Chapter 7. Global Drug Integrated Polymer Fibers Market - Regional Analysis
    • 7.1. Global Drug Integrated Polymer Fibers Market overview: by Region
      • 7.1.1. Global Drug Integrated Polymer Fibers Marketshare, by Region, 2018 and 2025
    • 7.2. North America
      • 7.2.1. North America Drug Integrated Polymer Fibers Market, 2016-2025 (USD Million)
      • 7.2.2. North America Drug Integrated Polymer Fibers Market revenue, By Type,2016-2025 (USD Million)
      • 7.2.3. North America Drug Integrated Polymer Fibers Market revenue, By Application, 2016-2025 (USD Million)
      • 7.2.4. The U.S.
        • 7.2.4.1. The U.S.Drug Integrated Polymer Fibers Marketrevenue, By Type,2016-2025 (USD Million)
        • 7.2.4.2. The U.S.Drug Integrated Polymer Fibers Market revenue, By Application, 2016-2025 (USD Million)
      • 7.2.5. Rest of North America
        • 7.2.5.1. Rest of North America Drug Integrated Polymer Fibers Market revenue, By Type,2016-2025 (USD Million)
        • 7.2.5.2. Rest of North America Drug Integrated Polymer Fibers Marketrevenue, By Application, 2016-2025 (USD Million)
    • 7.3. Europe
      • 7.3.1. Europe Drug Integrated Polymer Fibers Market, 2016-2025 (USD Million)
      • 7.3.2. Europe Drug Integrated Polymer Fibers Market revenue, By Type,2016-2025 (USD Million)
      • 7.3.3. Europe Drug Integrated Polymer Fibers Market revenue, By Application, 2016-2025 (USD Million)
      • 7.3.4. UK
        • 7.3.4.1. U.K.Drug Integrated Polymer Fibers Marketrevenue, By Type,2016-2025 (USD Million)
        • 7.3.4.2. U.K.Drug Integrated Polymer Fibers Market revenue, By Application, 2016-2025 (USD Million)
      • 7.3.5. France
        • 7.3.5.1. France Drug Integrated Polymer Fibers Marketrevenue, By Type,2016-2025 (USD Million)
        • 7.3.5.2. France Drug Integrated Polymer Fibers Marketrevenue, By Application, 2016-2025 (USD Million)
      • 7.3.6. Germany
        • 7.3.6.1. Germany Drug Integrated Polymer Fibers Marketrevenue, By Type,2016-2025 (USD Million)
        • 7.3.6.2. Germany Drug Integrated Polymer Fibers Market revenue, By Application, 2016-2025 (USD Million)
      • 7.3.7. Rest of Europe
        • 7.3.7.1. Rest of EuropeDrug Integrated Polymer Fibers Marketrevenue, By Type,2016-2025 (USD Million)
        • 7.3.7.2. Rest of EuropeDrug Integrated Polymer Fibers Market revenue, By Application, 2016-2025 (USD Million)
    • 7.4. Asia Pacific
      • 7.4.1. Asia Pacific Drug Integrated Polymer Fibers Market, 2016-2025 (USD Million)
      • 7.4.2. Asia Pacific Drug Integrated Polymer Fibers Marketrevenue, By Type,2016-2025 (USD Million)
      • 7.4.3. Asia Pacific Drug Integrated Polymer Fibers Market revenue, By Application, 2016-2025 (USD Million)
      • 7.4.4. China
        • 7.4.4.1. China Drug Integrated Polymer Fibers Market revenue, By Type,2016-2025 (USD Million)
        • 7.4.4.2. China Drug Integrated Polymer Fibers Marketrevenue, By Application, 2016-2025 (USD Million)
      • 7.4.5. Japan
        • 7.4.5.1. Japan Drug Integrated Polymer Fibers Market revenue, By Type,2016-2025 (USD Million)
        • 7.4.5.2. Japan Drug Integrated Polymer Fibers Marketrevenue, By Application, 2016-2025 (USD Million)
      • 7.4.6. India
        • 7.4.6.1. India Drug Integrated Polymer Fibers Market revenue, By Type,2016-2025 (USD Million)
        • 7.4.6.2. India Drug Integrated Polymer Fibers Market revenue, By Application, 2016-2025 (USD Million)
      • 7.4.7. Rest of Asia Pacific
        • 7.4.7.1. Rest of Asia Pacific Drug Integrated Polymer Fibers Marketrevenue, By Type,2016-2025 (USD Million)
        • 7.4.7.2. Rest of Asia Pacific Drug Integrated Polymer Fibers Market revenue, By Application, 2016-2025 (USD Million)
    • 7.5. Latin America
      • 7.5.1. Latin America Drug Integrated Polymer Fibers Market, 2016-2025 (USD Million)
      • 7.5.2. Latin America Drug Integrated Polymer Fibers Marketrevenue, By Type,2016-2025 (USD Million)
      • 7.5.3. Latin America Drug Integrated Polymer Fibers Marketrevenue, By Application, 2016-2025 (USD Million)
      • 7.5.4. Brazil
        • 7.5.4.1. Brazil Drug Integrated Polymer Fibers Marketrevenue, By Type,2016-2025 (USD Million)
        • 7.5.4.2. Brazil Drug Integrated Polymer Fibers Marketrevenue, By Application, 2016-2025 (USD Million)
      • 7.5.5. Rest of LatinAmerica
        • 7.5.5.1. Rest of LatinAmerica Drug Integrated Polymer Fibers Market revenue, By Type,2016-2025 (USD Million)
        • 7.5.5.2. Rest of LatinAmerica Drug Integrated Polymer Fibers Market revenue, By Application, 2016-2025 (USD Million)
    • 7.6. The Middle East and Africa
      • 7.6.1. The Middle East and Africa Drug Integrated Polymer Fibers Market, 2016-2025 (USD Million)
      • 7.6.2. The Middle East and Africa Drug Integrated Polymer Fibers Market revenue, By Type,2016-2025 (USD Million)
      • 7.6.3. The Middle East and Africa Drug Integrated Polymer Fibers Marketrevenue, By Application, 2016-2025 (USD Million)
  • Chapter 8. Company Profiles
    • 8.1. TissueGen, Inc.
      • 8.1.1. Overview
      • 8.1.2. Financials
      • 8.1.3. Type Portfolio
      • 8.1.4. Business Strategy
      • 8.1.5. Recent Developments
    • 8.2. Integrated Polymer Solutions
      • 8.2.1. Overview
      • 8.2.2. Financials
      • 8.2.3. Type Portfolio
      • 8.2.4. Business Strategy
      • 8.2.5. Recent Developments
    • 8.3. Micro Engineering Solutions
      • 8.3.1. Overview
      • 8.3.2. Financials
      • 8.3.3. Type Portfolio
      • 8.3.4. Business Strategy
      • 8.3.5. Recent Developments

Table Of Figures

List of Figures

1. Market research process
2. Market research methodology
3. Global drug integrated polymer fibers market, 2019 - 2025 (USD Million)
4. Porter’s five forces analysis: drug integrated polymer fibers market
5. Global drug integrated polymer fibers market attractiveness, by type
6. Global drug integrated polymer fibers market attractiveness, by application
7. Global drug integrated polymer fibers market revenue share, by type, 2019 and 2025
8. Global drug integrated polymer fibers market by polylactic acid (PLA), 2019 - 2025 (USD Million)
9. Global drug integrated polymer fibers market by polydioxanone (PDO), 2019 - 2025 (USD Million)
10. Global drug integrated polymer fibers market by polycaprolactone (PCL), 2019 - 2025 (USD Million)
11. Global drug integrated polymer fibers market by others (PGA, PLGA, PDLL), 2019 - 2025 (USD Million)
12. Global drug integrated polymer fibers market revenue share, by application, 2019 and 2025
13. Global drug integrated polymer fibers market by drug delivery, 2019 - 2025 (USD Million)
14. Global drug integrated polymer fibers market by orthopedic sutures, 2019 - 2025 (USD Million)
15. Global drug integrated polymer fibers market by vascular stents, 2019 - 2025 (USD Million)
16. Global drug integrated polymer fibers market by vascular grafts, 2019 - 2025 (USD Million)
17. Global drug integrated polymer fibers market by dermal wound healing, 2019 - 2025 (USD Million)
18. Global drug integrated polymer fibers market by others, 2019 - 2025 (USD Million)
19. Global drug integrated polymer fibers market revenue share, by region, 2019 & 2025
20. North America drug integrated polymer fibers market, 2019 - 2025 (USD Million)
21. Europe drug integrated polymer fibers market, 2019 - 2025 (USD Million)
22. Asia Pacific drug integrated polymer fibers market, 2019 – 2025 (USD Million)
23. Latin America drug integrated polymer fibers market, 2019 - 2025 (USD Million)
24. Middle East & Africa drug integrated polymer fibers market, 2019 – 2025 (USD Million)


Table Of Tables

List of Tables

1. Global drug integrated polymer fibers market: snapshot
2. Drivers for drug integrated polymer fibers market: impact analysis
3. Restraints for drug integrated polymer fibers market: impact analysis
4. North America drug integrated polymer fibers market revenue, by country, 2019 – 2025 (USD Million)
5. North America drug integrated polymer fibers market revenue, by type, 2019 – 2025 (USD Million)
6. North America drug integrated polymer fibers market revenue, by application, 2019 – 2025 (USD Million)
7. The U.S. drug integrated polymer fibers market revenue, by type, 2019 – 2025 (USD Million)
8. The U.S. drug integrated polymer fibers market revenue, by application, 2019 – 2025 (USD Million)
9. Rest of North America drug integrated polymer fibers market revenue, by type, 2019 – 2025 (USD Million)
10. Rest of North America drug integrated polymer fibers market revenue, by application, 2019 – 2025 (USD Million)
11. Europe drug integrated polymer fibers market revenue, by country, 2019 – 2025 (USD Million)
12. Europe drug integrated polymer fibers market revenue, by type, 2019 – 2025 (USD Million)
13. Europe drug integrated polymer fibers market revenue, by application, 2019 – 2025 (USD Million)
14. U.K. drug integrated polymer fibers market revenue, by type, 2019 – 2025 (USD Million)
15. U.K. drug integrated polymer fibers market revenue, by application, 2019 – 2025 (USD Million)
16. France drug integrated polymer fibers market revenue, by type, 2019 – 2025 (USD Million)
17. France drug integrated polymer fibers market revenue, by application, 2019 – 2025 (USD Million)
18. Germany drug integrated polymer fibers market revenue, by type, 2019 – 2025 (USD Million)
19. Germany drug integrated polymer fibers market revenue, by application, 2019 – 2025 (USD Million)
20. Rest of Europe drug integrated polymer fibers market revenue, by type, 2019 – 2025 (USD Million)
21. Rest of Europe drug integrated polymer fibers market revenue, by application, 2019 – 2025 (USD Million)
22. Asia Pacific drug integrated polymer fibers market revenue, by country, 2019 – 2025 (USD Million)
23. Asia Pacific drug integrated polymer fibers market revenue, by type, 2019 – 2025 (USD Million)
24. Asia Pacific drug integrated polymer fibers market revenue, by application, 2019 – 2025 (USD Million)
25. China drug integrated polymer fibers market revenue, by type, 2019 – 2025 (USD Million)
26. China drug integrated polymer fibers market revenue, by application, 2019 – 2025 (USD Million)
27. Japan drug integrated polymer fibers market revenue, by type, 2019 – 2025 (USD Million)
28. Japan drug integrated polymer fibers market revenue, by application, 2019 – 2025 (USD Million)
29. India drug integrated polymer fibers market revenue, by type, 2019 – 2025 (USD Million)
30. India drug integrated polymer fibers market revenue, by application, 2019 – 2025 (USD Million)
31. Rest of Asia Pacific drug integrated polymer fibers market revenue, by type, 2019 – 2025 (USD Million)
32. Rest of Asia Pacific drug integrated polymer fibers market revenue, by application, 2019 – 2025 (USD Million)
33. Latin America drug integrated polymer fibers market revenue, by country, 2019 – 2025 (USD Million)
34. Latin America drug integrated polymer fibers market revenue, by type, 2019 – 2025 (USD Million)
35. Latin America drug integrated polymer fibers market revenue, by application, 2019 – 2025 (USD Million)
36. Brazil drug integrated polymer fibers market revenue, by type, 2019 – 2025 (USD Million)
37. Brazil drug integrated polymer fibers market revenue, by application, 2019 – 2025 (USD Million)
38. Rest of Latin America drug integrated polymer fibers market revenue, by type, 2019 – 2025 (USD Million)
39. Rest of Latin America drug integrated polymer fibers market revenue, by application, 2019 – 2025 (USD Million)
40. Middle  East & Africa drug integrated polymer fibers market revenue, by type, 2019 – 2025 (USD Million)
41. Middle  East & Africa drug integrated polymer fibers market revenue, by application, 2019 – 2025 (USD Million)

Methodology

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • paypal
  • amazon
  • visa
  • master card

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed